4.7 Review

Functions and mechanisms of microRNA-31 in human cancers

期刊

BIOMEDICINE & PHARMACOTHERAPY
卷 108, 期 -, 页码 1162-1169

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2018.09.132

关键词

MiR-31; Pathways; Tumorigenesis

资金

  1. National Natural Science Foundation of China [81572262, 81672896, 81802381]
  2. Natural Science Foundation of Jiangsu Province [BK20151583]
  3. Jiangsu Province's Key Provincial Talents Program [ZDRCA2016028]
  4. 333 High Class Talented Man Project [BRA2016516]
  5. Six Talents Peak Project of Jiangsu Province [2013-wsn-032]
  6. National Key Research and Development Program: The Key Technology of Palliative Care and Nursing for Cancer Patients [ZDZX2017ZL-01]
  7. Nanjing Medical University High Level Innovation Team Program [JX102GSP201727]

向作者/读者索取更多资源

MicroRNAs can exhibit opposite functions in different tumors. MiR-31 is a representative example as it can not only enhance tumor development and progression in pancreatic cancer, colorectal cancer and so on, but also inhibit tumorigenesis and induce apoptosis in ovarian cancer, prostate cancer and etc. The mechanism underlying its' pleiotropy remains unknown. Several recent studies that focused on the global gene expression changes caused by aberrant miR-31 provided information on the upstream and downstream events associated with deregulated miR-31. MiR-31 might interact with a number of signaling pathways including RAS/MARK, PI3K/AKT and RB/E2F to play its opposite functions. This review summarizes the target genes and pathways associated with miR-31 and examines the mechanisms underlying the function of miR-31. The resulting hypothesis is possible that the tissue-specific features of adenocarcinoma and squamous cell cancer and the positive feedback loop consists of miR-31 and its upstream and downstream may account for the diversity of miR-31 functions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据